Using siRNA in prophylactic and therapeutic regimens against SARS coronavirus in Rhesus macaque-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Using siRNA in prophylactic and therapeutic regimens against SARS coronavirus in Rhesus macaque

Published:2005-08-21 Issue:9 Volume:11 Page:944-951
ISSN:1078-8956
Container-title:Nature Medicine
language:en
Short-container-title:Nat Med

Author:

Li Bao-jian,Tang Qingquan,Cheng Du,Qin Chuan,Xie Frank Y,Wei Qiang,Xu Jun,Liu Yijia,Zheng Bo-jian,Woodle Martin C,Zhong Nanshan,Lu Patrick Y

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://www.nature.com/articles/nm1280.pdf

Reference50 articles.

1. Fouchier, R.A. et al. Aetiology: Koch's postulates fulfilled for SARS virus. Nature 423, 240 (2003).

2. Kuiken, T. et al. Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome. Lancet 362, 263–270 (2003).

3. Ksiazek, T.G. et al. A novel coronavirus associated with severe acute respiratory syndrome. N. Engl. J. Med. 348, 1953–1966 (2003).

4. Peiris, J.S. et al. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet 361, 1319–1325 (2003).

5. Guan, Y. et al. Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China. Science 302, 276–278 (2003).

Cited by 393 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. RNAi-based drug design: considerations and future directions;Nature Reviews Drug Discovery;2024-04-03

2. RNAi-mediated inhibition of SARS-CoV-2: applications and challenges;Future Virology;2024-03-03

3. RNA therapeutics for respiratory diseases;Progress in Molecular Biology and Translational Science;2024

4. The Use of Animal Models for Antiviral Therapeutics Development: Opportunities and Challenges;Livestock Diseases and Management;2024

5. Potential therapeutic landscape of COVID-19: molecular targets, repurposed drugs, and nano- and cell-based intervention;Stem Cells;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3